Article Text

Download PDFPDF
Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis
  1. Iker Badiola1,
  2. Elvira Olaso2,
  3. Olatz Crende2,
  4. Scott L Friedman3,
  5. Fernando Vidal-Vanaclocha4
  1. 1Innoprot SL, Bizkaia, Spain
  2. 2Department of Cell Biology and Histology, School of Medicine and Dentistry, University of the Basque Country, Leioa, 48940 Bizkaia, Spain
  3. 3Division of Liver Diseases, Mount Sinai School of Medicine, New York, New York, USA
  4. 4Institute of Applied Molecular Medicine, CEU-San Pablo University School of Medicine, and Hospital of Madrid scientific foundation Madrid, Spain
  1. Correspondence to Dr Elvira Olaso, Department of Cell Biology and Histology, School of Medicine and Dentistry, University of the Basque Country, Leioa, Bizkaia 48940, Spain; elvira.olaso{at}


Background The transdifferentiation of hepatic stellate cells (HSCs) into myofibroblasts is a major mechanism for stroma development in hepatic metastasis, but their regulatory pathways remain unclear. Transdifferentiated HSCs from fibrotic liver express high levels of the fibrillar collagen receptor discoidin domain receptor 2 (DDR2), but it is unclear if DDR2 plays a direct profibrogenic role in the tumour microenvironment.

Aim To assess the impact of DDR2 on the prometastatic role of HSC-derived myofibroblasts.

Methods Hepatic metastases were induced in DDR2−/− and DDR2+/+ mice by intrasplenic injection of MCA38 colon carcinoma cells, and their growth and features were characterised. Stromagenic, angiogenic and cancer cell proliferation responses were quantified in metastases by immunohistochemistry. The adhesion-, migration- and proliferation-stimulating activities of supernatants from primary cultured DDR2−/− and DDR2+/+ HSCs, incubated in MCA38 cell-conditioned medium, were evaluated in primary cultured liver sinusoidal endothelium cells (LSECs) and MCA38 cells. Gene expression signatures from freshly isolated DDR2−/− and DDR2+/+ HSCs were compared and DDR2-regulated genes were studied by RT-PCR under basal conditions and after stimulation with MCA38 tumour-conditioned media.

Results Metastases were increased three fold in DDR2−/− livers, and contained a higher density of α−smooth muscle actin-expressing myofibroblasts, CD31-expressing microvessels and Ki67-expressing MCA38 cells than metastases in DDR2+/+ livers. Media conditioned by MCA38-activated DDR2−/− HSCs significantly increased adhesion, migration and proliferation of LSECs and MCA38 cells, compared with DDR2+/+ HSCs. DDR2 deficiency in HSCs led to decreased gene expression of interferon γ-inducing factor interleukin (IL)-18 and insulin-like growth factor-I; and increased gene expression of prometastatic factors IL-10, transforming growth factor (TGF)β and vascular endothelial growth factor (VEGF), bone morphogenetic protein-7 and syndecan-1. MC38 tumour-conditioned media further exacerbated expression changes in DDR2-dependent IL-10, TGFβ and VEGF genes.

Conclusion DDR2 deficiency fosters the myofibroblast transdifferentiation of tumour-activated HSCs, generating a prometastatic microenvironment in the liver via HSC-derived factors. These findings underscore the role of stromal cells in conditioning the hepatic microenvironment for metastases through altered receptor–stroma interactions.

  • DDR2
  • liver metastasis
  • colon carcinoma
  • collagen
  • extracellular matrix
  • collagen receptor
  • hepatic stellate cells
  • tumour stroma
  • hepatic metastasis
  • cell matrix interaction
  • cancer
  • hepatic metastases
  • colorectal cancer
  • hepatic stellate cell
  • angiogenesis
  • endothelial cells

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • IB and EO contributed equally to this work.

  • Funding This work was supported in part by grants from the Spanish Ministry of Health (FIS04/2785), International Association for Cancer Research (04-274) and Basque Government Department of Industry (SAIOTEK) to EO; grants from NIH (DK37340 and DK56621) to SLF; Spanish Ministry of Innovation and Science (SAF2009-12376) and Basque Government Department of Education (IT-487-07) to FVV and EO, and The Spanish coslos III Health Institute (ADE09/90041 and The Burdinola profesorship on molecular medicine to FVV.

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles